2nd Quarter - Report

INVARIANT LLC for ANTHEIA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients. Encourage support for federal loan programs for technology to strengthen our domestic supply chain for pharmaceuticals and S. 1260, United States Innovation and Competition Act of 2021.

LobbyistCovered position, as disclosed
CHRISTOPHER GILLOTT —
BENJAMIN KLEIN —
ANNABELL MCWHERTER STOKES —
KATHRYN WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.